UNC REX Cancer Care Annual Report 2015
Total Page:16
File Type:pdf, Size:1020Kb
UNC REX CANCER CARE ANNUAL REPORT 2015 ANNUAL REPORT 2015 A COMPREHENSIVE COMMUNITY CANCER PROGRAM Accredited by the American College of Surgeons Commission on Cancer National Accreditation Program for Breast Centers Cary Garner Raleigh Main Raleigh Blue Ridge Wakefield On the cover: UNC REX Cancer Care-Cary 150 Parkway Office Court Parkway Professional Park, Suite 200 Cary, NC 27518 UNC REX Cancer Care locations Cary ~ Garner ~ Raleigh Main ~ Raleigh Blue Ridge ~Wakefield For more information or to schedule an appointment with UNC REX Cancer Care Call 919-784-3105 www.REXhealth.com/rh/care-treatment/cancer/unc-REX-cancer-care-locations/ ANNUAL REPORT | 3 UNC REX Cancer Care Mission and Core Values Mission The mission of UNC REX Cancer Care is to provide our patients with exceptional cancer care and to ensure timely and convenient access to the most effective strategies that prevent, treat, and ultimately cure cancer in the future. UNC REX Cancer Care provides expert, compassionate care to patients with cancer through close collaboration among providers across all disciplines of oncology. Core Values Impact We strive to provide timely access to care in a caring and compassionate setting close to patients’ homes and to relieve the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy. Excellence We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct. Compassion and Respect We strive to exceed expectations for compassion and respect for those in our care and for one another. ANNUAL REPORT | 4 UNC REX Cancer Care Annual Report 2015 Table of Contents Page . Mission & Core Values 3 . Introduction 5 . Accreditations and Requirements 6 . Annual Study of Quality 2015 7 . Tumor Registry & Site Distribution 11 . Quality Accountability Measures 13 . Publications and Presentations 2015 14 . Community Outreach and Education 15 . Comprehensive Community Cancer Care 16 . Cancer Care Services and Locations 17 ANNUAL REPORT | 5 Introduction The REX Cancer Care Committee is the designated multidisciplinary body for program leadership and administrative oversight, development, and review of oncology services and care at UNC REX Cancer Care. The Cancer Care Committee is an official UNC REX Hospital Medical Staff committee responsible for the overall direction of the oncology program including coordination with Hospital and UNC Health System leadership. Its composition, as required by the Commission on Cancer, includes board-certified physicians from Surgery, Medical Oncology, Radiation Oncology, Diagnostic Radiology, and Pathology, along with the Cancer Liaison Physician, Clinical Research Manager, Palliative Care Specialist, and representatives from Hospital Administration, Nursing, Pharmacy, Psycho-social services, Cancer registry, and Quality. Annually, as required by the Commission on Cancer, the UNC REX Cancer Care Committee identifies a designated topic of relevance and interest for comprehensive study and evaluation. For 2015, the Committee chose Cancer Genetics for its annual study. The results of that study are detailed in the following pages of this Annual Report. These findings are published through the UNC REX Cancer Annual Report and made publicly available to the organization and the community. Cancer Care Committee Membership 2015 . Jeff Crane, MD Chairman . Yale Podnos, MD ACoS Cancer Liaison Physician/ Surgical Oncology . Susan Moore, MD Medical Director, REX Cancer Center . David B. Eddleman, MD Surgeon / Breast Care Committee Chair . Tom Grates, MBA Cancer Center Executive Director . Chad Lefteris, MHA VP / UNC REX Hospital Administration . Alden Parsons, MD Cancer Conference Coordinator/ Thoracic Surgery . Charles Eisenbeis, MD Hematology Oncology . Nathan Sheets, MD Radiation Oncology . Keith Volmar, MD Pathology . Jay Alley, MD Radiology . Kathleen Foote, CTR Cancer Registry Coordinator / Manager . Nancy Burns, RN, OCN Cancer Research Coordinator / Manager . Cynthia Jones, BS, CPHQ Quality Coordinator . Kimberly Fradel, MSW,LCSW Social Work /Psychosocial Services Coordinator . Toni Miller, NP Palliative Care . Mendy Moody, MSN, OCN Oncology Nurse Manager/ Clinical Leadership . Catherine Fine, MS, CGC / Ofri Leitner, MS, CGC Genetic Counseling . Emmeline Madsen, MPH Community Outreach Coordinator / Manager Additional Supporting General Membership 2015 Matthew Strouch, MD ~ Surgery Douglas Hammer, MD ~ Family Practice Meena Mohan, MD ~ Hospitalist Robert Wehbie, MD ~ Medical Oncology Jon Gerber, PharmD ~ OP Pharmacy Becky Jones, PharmD ~ IP Pharmacy Jennifer Headen, MHA~ RHOA Adm Christopher Wood, RT, MBA~ Radiation Oncology Adm Nancy Reifsteck, OTR ~Rehab Gwyn Hardin, RD, LDN Claudia Hepburn, RN, OCN ~Mgr (OP) Deb Andersson, RN ~Mgr (IP) Kelly McLaughlin, MSN, OCN ~Mgr (OP) Heather Sasser, RN, OCN ~Mgr (OP) Vicky Burton, Staff /Committee Assistant Robbie Tilley, American Cancer Society ANNUAL REPORT | 6 UNC REX Cancer Care Accreditations UNC REX Cancer Care is voluntarily accredited by the American College of Surgeons Commission (ACoS) per the Commission on Cancer (CoC) Standards as a Comprehensive Community Cancer Program (CCCP). The pro- gram assesses more than 500 newly diagnosed cancer cases each year, provides a full range of diagnostic and comprehensive treatment services as noted below, either on-site or by referral, as well as participates in cancer- related clinical research and cancer-related clinical trials, per CoC Standards. UNC REX Cancer Care in addition, is also voluntarily accredited by the National Accreditation Program for Breast Centers (NAPBC). The NAPBC holds organizations to the highest standards of care for patients with dis- eases of the breast. UNC REX Cancer Care is also accredited by the Joint Commission UNC REX Cancer Care meets and /or exceeds the Commission on Cancer 12 Eligibility Requirements: Eligibility Requirements Specifications Cancer Committee Responsibilities Annual monitoring, assessing, and identifying changes that are needed in each of the eligibility requirements. Facility Accreditation The facility is accredited by a recognized federal, state, or local authority. Cancer Committee Authority Bylaws or policy and procedure define the cancer committee’s authority and responsibility for the program. Cancer Conference Policy Program policy addresses the frequency, format, multidisciplinary attendance, attendance rate, prospective case presentations and total case presentations, discussion of stage and treatment planning, clinical trial options, and methods to address opportunities. Oncology Nurse Leadership An oncology nurse provides leadership within the program. Cancer Registry Policy & Procedure Policy and procedure addresses the use of Commission on Cancer data & all other cancer registry activities. Diagnostic Imaging Services are provided. * Radiation Oncology Services Radiation treatment service locations are currently accredited by a recognized authority or, if not accredited, follow standard quality assurance practices. * Systemic Services Policies or procedures are in place to guide the safe administration of systemic therapy.* Clinical Trial Information A policy or procedure is used to inform patients about clinical trials. Psychosocial Services A policy or procedure is in place to ensure patient access to psychosocial ser- vices.* Rehabilitation Services Rehabilitative services are provided. * Nutrition Services Nutrition services are provided.* Source: CoC,Ad 2014 pat * Servicespublinvente are available either eludem on-site, at locations o that are facility owned, or by referral. consuli aleme conclerora ANNUAL REPORT | 7 Annual Study 2015: Cancer Genetics Maha A. Elkordy, MD, MPH; Catherine Fine, MS, CGC; Ofri Leitner, MS, CGC; Cynthia Jones, BS, CPHQ INTRODUCTION The field of medical oncology is continuously evolving, and one of the most rapidly growing areas is that of cancer genetics. While the majority of cancers are not due to a hereditary cause, it is estimated that 5-10% of each type of cancer may be due to an inherited predisposition. Compared to the general population, individuals with a known ge- netic predisposition have a higher risk of developing certain cancers in their lifetime, which may develop at a younger age than what is typical. Having a genetic predisposition to cancer directly impacts an individual’s cancer screening recommendations, allows individuals to take advantage of cancer risk-reduction interventions, and provides valuable information for an individual’s family members. CANCER GENES All cancer has a genetic basis and genetic testing can be performed to look for changes (mutations) in genes related to a specific cancer type. There are two categories of such testing, and each provides different information to patients and their providers: germline genetic testing and somatic genetic testing. Germline genetic testing is typically performed using an individual’s blood or saliva sample, in order to identify muta- tions that were inherited from a parent. If such a mutation is found in an individual, it is present in every cell of the body and can pass from generation to generation. Somatic genetic testing is typically done on tumor tissue to identify acquired mutations that are only present in that tissue and are not inherited. These acquired mutations typically occur due to factors such as aging and environmental exposures such as tobacco, ultraviolet radiation, and viruses. Acquired mutations are the most common